Russell Investments Group, Ltd.
Position in BCRX — Biocryst Pharmaceuticals Inc
CIK 1692234
Seattle, WA
Position in BCRX
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$746,990
-$1,839,286 QoQ
Shares Held
74,699
-72.5% QoQ
Ownership
0.029%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#136
of 316 holders
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 94%
Shared 0%
None 6%
Common Shares in BCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Russell Investments Group, Ltd. holds $362,370,004 across 49 Drug Manufacturers - Specialty & Generic names. BCRX ranks #27 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
893,500 | $64,206,902 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
329,065 | $55,460,607 | |
| 3 | VTRS |
Viatris Inc
|
3,423,675 | $54,367,956 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
61,355 | $33,243,974 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
1,112,894 | $27,388,318 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
147,146 | $16,324,370 | |
| 7 | TEVA |
Teva Pharmaceutical Industries Ltd
|
427,444 | $14,481,798 | |
| 8 | ALKS |
Alkermes plc.
|
222,624 | $11,665,496 |
All Filings in BCRX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $746,990 | 74,699 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $2,586,276 | 271,668 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $1,787,959 | 229,226 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $2,386,998 | 314,493 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $3,944,629 | 440,249 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $774,967 | 103,329 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $210,304 | 27,966 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $114,189 | 15,025 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $514,502 | 83,253 | Shares | Defined | 2024-08-08 | |
| 2024-03-31 | $298,322 | 58,725 | Shares | Defined | 2024-05-08 | |
| 2023-12-31 | $116,924 | 19,520 | Shares | Defined | 2024-02-05 | |
| 2023-09-30 | $146,973 | 20,759 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $342,704 | 48,680 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $1,435,853 | 172,165 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $1,733,397 | 150,993 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $1,602,404 | 127,175 | Shares | Defined | 2022-11-04 | |
| 2022-06-30 | $2,618,781 | 247,522 | Shares | Sole | 2022-07-29 | |
| 2022-03-31 | $1,307,725 | 80,426 | Shares | Defined | 2022-05-05 | |
| 2021-12-31 | $28,572 | 2,063 | Shares | Defined | 2022-01-21 | |
| 2021-09-30 | $29,645 | 2,063 | Shares | Defined | 2021-11-08 | |
| 2020-03-31 | $323,614 | 161,807 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||